The day after the green light from the European Medicines Agency, the Haute Haute Autorité de Santé (HAS) authorized the Janssen vaccine from the Johnson & Johnson laboratory on French soil.

The HAS also recommends using this serum, "preferentially" in areas where the epidemic is "particularly active".

The High Authority for Health (HAS) on Friday authorized Johnson & Johnson's Covid-19 vaccine in France, the day after the European green light, recommending use "preferentially" in areas where the epidemic is "particularly active".

>> LIVE -

Coronavirus: follow the evolution of the situation Friday March 12

The health authority believes that this American single injection vaccine, the fourth to be authorized in France, "can be used from the age of 18", "including in people aged 65 and over and / or "at risk for serious forms of Covid.